Michael C. Donegan, Principal Fin. and Accounting Officer at TherapeuticsMD, Inc. (TXMD), sold 1,697 shares at $5.08 ($9K) on 2023-01-26, disclosed to the SEC on 2023-01-30.
Open-market sale of $9k TXMD by Principal Fin. and Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.08 | 1,648 | $8K | 97.1% |
| 2 | $5.09 | 49 | $249 | 2.9% |
| Total | $5.08 avg | 1,697 | $9K | 100% |
| Filing → |
| TXMD | SELL | 2021-12-02 | $16K | — | Filing → |
| TXMD | SELL | 2021-05-12 | $5K | — | Filing → |